IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
ADJUVANT POST-SURGERY THERAPY WITH IMATINIB IN INTERMEDIATE OR HIGH-RISK GASTROINTESTINAL STROMAL TUMOUR (GIST) PATIENTS: INTERIM ANALYSIS FROM A SINGLE CENTRE COMPARISON STUDY
Shen, L.; Li, J.; Li, J.; Gong, J.; Wu, A.
刊名ANNALS OF ONCOLOGY
2008-09-01
19页:267-267
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000259973300867
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59831
Collection北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位Peking Univ, Sch Oncol, Dept Gastrointestinal Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
Recommended Citation
GB/T 7714
Shen, L.,Li, J.,Li, J.,et al. ADJUVANT POST-SURGERY THERAPY WITH IMATINIB IN INTERMEDIATE OR HIGH-RISK GASTROINTESTINAL STROMAL TUMOUR (GIST) PATIENTS: INTERIM ANALYSIS FROM A SINGLE CENTRE COMPARISON STUDY[J]. ANNALS OF ONCOLOGY,2008,19:267-267.
APA Shen, L.,Li, J.,Li, J.,Gong, J.,&Wu, A..(2008).ADJUVANT POST-SURGERY THERAPY WITH IMATINIB IN INTERMEDIATE OR HIGH-RISK GASTROINTESTINAL STROMAL TUMOUR (GIST) PATIENTS: INTERIM ANALYSIS FROM A SINGLE CENTRE COMPARISON STUDY.ANNALS OF ONCOLOGY,19,267-267.
MLA Shen, L.,et al."ADJUVANT POST-SURGERY THERAPY WITH IMATINIB IN INTERMEDIATE OR HIGH-RISK GASTROINTESTINAL STROMAL TUMOUR (GIST) PATIENTS: INTERIM ANALYSIS FROM A SINGLE CENTRE COMPARISON STUDY".ANNALS OF ONCOLOGY 19(2008):267-267.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Shen, L.]'s Articles
[Li, J.]'s Articles
[Li, J.]'s Articles
百度学术
百度学术Similar articles in
[Shen, L.]'s Articles
[Li, J.]'s Articles
[Li, J.]'s Articles
必应学术
必应学术Similar articles in
[Shen, L.]'s Articles
[Li, J.]'s Articles
[Li, J.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.